4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-001823
Options or other derivatives
- 10% owner bought 8,695,653 shares
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-01-10 | Purchase · Series B Convertible Preferred Stock | +3,478,261 | 3,478,261 | D: show line 1 in the form | ||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-01-10 | Purchase · Series A Warrants to Purchase Common Stock | +2,608,696 | 2,608,696 | D: show line 2 in the form | ||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2018-01-10 | Purchase · Series B Warrants to Purchase Common Stock | +2,608,696 | 2,608,696 | D: show line 3 in the form |
Loading xslF345X03/tv483130_4.xml…